About CSL Behring

Thank you for requesting an Educational Grant from CSL Behring. CSL Behring is a global leader in saving and improving the lives of people with rare and serious medical disorders. We research, develop, manufacture and market plasma-derived and recombinant biotherapies that target therapeutic areas including:

  • Coagulation
  • Acquired Bleeding Disorders
  • Immune Deficiency
  • Alpha-1 Antitrypsin
  • Hereditary Angioedema (HAE)

Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in everything we do. Whether we are manufacturing safe and effective products or supporting educational programs, we are first and foremost focused on fulfilling our customers’ needs.